

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 7.10953640 |
| 2 | translational termination (GO:0006415) | 6.67219332 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.95433873 |
| 4 | translational elongation (GO:0006414) | 5.91504894 |
| 5 | cotranslational protein targeting to membrane (GO:0006613) | 5.83740002 |
| 6 | protein targeting to ER (GO:0045047) | 5.81818221 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.61148883 |
| 8 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.56936636 |
| 9 | protein localization to endoplasmic reticulum (GO:0070972) | 5.48860632 |
| 10 | viral life cycle (GO:0019058) | 5.41259652 |
| 11 | chaperone-mediated protein transport (GO:0072321) | 5.20911592 |
| 12 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.18664674 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.15679250 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 5.15679250 |
| 15 | cellular protein complex disassembly (GO:0043624) | 5.08887081 |
| 16 | translational initiation (GO:0006413) | 4.90466487 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.64624246 |
| 18 | protein complex disassembly (GO:0043241) | 4.48796395 |
| 19 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.28852191 |
| 20 | translation (GO:0006412) | 4.24404503 |
| 21 | macromolecular complex disassembly (GO:0032984) | 4.21496324 |
| 22 | protein targeting to membrane (GO:0006612) | 4.02306655 |
| 23 | DNA deamination (GO:0045006) | 4.00362186 |
| 24 | respiratory electron transport chain (GO:0022904) | 3.98595473 |
| 25 | protein complex biogenesis (GO:0070271) | 3.95796706 |
| 26 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.95305507 |
| 27 | electron transport chain (GO:0022900) | 3.90805980 |
| 28 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.89727106 |
| 29 | rRNA catabolic process (GO:0016075) | 3.80518256 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.70616306 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.70616306 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 3.70616306 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.69644424 |
| 34 | formation of translation preinitiation complex (GO:0001731) | 3.66710498 |
| 35 | protein targeting to mitochondrion (GO:0006626) | 3.65969988 |
| 36 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.64946838 |
| 37 | cellular component biogenesis (GO:0044085) | 3.58509280 |
| 38 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.58110592 |
| 39 | oxidative phosphorylation (GO:0006119) | 3.57848972 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.50552925 |
| 41 | negative regulation of ligase activity (GO:0051352) | 3.48938565 |
| 42 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.48938565 |
| 43 | mRNA catabolic process (GO:0006402) | 3.47736474 |
| 44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.43533868 |
| 45 | regulation of RIG-I signaling pathway (GO:0039535) | 3.42278332 |
| 46 | establishment of protein localization to mitochondrion (GO:0072655) | 3.41985512 |
| 47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41316812 |
| 48 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.38138885 |
| 49 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.37321800 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.37009449 |
| 51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.35724586 |
| 52 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.34455593 |
| 53 | proteasome assembly (GO:0043248) | 3.34344462 |
| 54 | ribosomal large subunit biogenesis (GO:0042273) | 3.30396430 |
| 55 | rRNA modification (GO:0000154) | 3.29034619 |
| 56 | negative regulation of B cell apoptotic process (GO:0002903) | 3.27639823 |
| 57 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.26696850 |
| 58 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.26696850 |
| 59 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.26254360 |
| 60 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.26254360 |
| 61 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.26254360 |
| 62 | protein localization to mitochondrion (GO:0070585) | 3.25369691 |
| 63 | RNA catabolic process (GO:0006401) | 3.23918723 |
| 64 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21248616 |
| 65 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21248616 |
| 66 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.21132111 |
| 67 | spliceosomal snRNP assembly (GO:0000387) | 3.19534920 |
| 68 | telomere maintenance via recombination (GO:0000722) | 3.18303635 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.18265917 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.17948278 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.12968574 |
| 72 | DNA strand elongation (GO:0022616) | 3.12964863 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.12313395 |
| 74 | rRNA processing (GO:0006364) | 3.12112762 |
| 75 | GTP biosynthetic process (GO:0006183) | 3.09418605 |
| 76 | purine nucleotide salvage (GO:0032261) | 3.09408649 |
| 77 | base-excision repair, AP site formation (GO:0006285) | 3.09277544 |
| 78 | CENP-A containing nucleosome assembly (GO:0034080) | 3.07083078 |
| 79 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.06933713 |
| 80 | protein neddylation (GO:0045116) | 3.06391969 |
| 81 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.04677605 |
| 82 | ATP biosynthetic process (GO:0006754) | 3.03180448 |
| 83 | UTP biosynthetic process (GO:0006228) | 3.02964433 |
| 84 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.01514709 |
| 85 | nucleotide salvage (GO:0043173) | 2.99165432 |
| 86 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.99012585 |
| 87 | inner mitochondrial membrane organization (GO:0007007) | 2.98643492 |
| 88 | histone-serine phosphorylation (GO:0035404) | 2.98535616 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.97860134 |
| 90 | rRNA methylation (GO:0031167) | 2.97766964 |
| 91 | positive regulation of protein homodimerization activity (GO:0090073) | 2.97223102 |
| 92 | mitotic recombination (GO:0006312) | 2.97065456 |
| 93 | kinetochore assembly (GO:0051382) | 2.96489678 |
| 94 | rRNA metabolic process (GO:0016072) | 2.94915333 |
| 95 | establishment of viral latency (GO:0019043) | 2.94870272 |
| 96 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.94615298 |
| 97 | telomere maintenance via telomere lengthening (GO:0010833) | 2.93641980 |
| 98 | tRNA methylation (GO:0030488) | 2.93286159 |
| 99 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92291064 |
| 100 | cytochrome complex assembly (GO:0017004) | 2.91788277 |
| 101 | chromatin remodeling at centromere (GO:0031055) | 2.91711456 |
| 102 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.91572075 |
| 103 | establishment of protein localization to membrane (GO:0090150) | 2.90361318 |
| 104 | pentose metabolic process (GO:0019321) | 2.88458532 |
| 105 | nucleoside salvage (GO:0043174) | 2.87878633 |
| 106 | DNA replication checkpoint (GO:0000076) | 2.87040225 |
| 107 | cellular response to exogenous dsRNA (GO:0071360) | 2.81747402 |
| 108 | cyclooxygenase pathway (GO:0019371) | 2.80861728 |
| 109 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.79330186 |
| 110 | positive regulation of B cell differentiation (GO:0045579) | 2.77818429 |
| 111 | fatty acid homeostasis (GO:0055089) | 2.77495813 |
| 112 | response to UV-B (GO:0010224) | 2.74992677 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74501948 |
| 114 | pantothenate metabolic process (GO:0015939) | 2.74440545 |
| 115 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.70540182 |
| 116 | termination of RNA polymerase III transcription (GO:0006386) | 2.69813055 |
| 117 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.69813055 |
| 118 | amino acid salvage (GO:0043102) | 2.69379444 |
| 119 | L-methionine salvage (GO:0071267) | 2.69379444 |
| 120 | L-methionine biosynthetic process (GO:0071265) | 2.69379444 |
| 121 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.68748628 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 2.67314132 |
| 123 | termination of RNA polymerase I transcription (GO:0006363) | 2.67107544 |
| 124 | purine nucleobase biosynthetic process (GO:0009113) | 2.66400990 |
| 125 | iron-sulfur cluster assembly (GO:0016226) | 2.65017804 |
| 126 | metallo-sulfur cluster assembly (GO:0031163) | 2.65017804 |
| 127 | negative regulation of telomere maintenance (GO:0032205) | 2.63802497 |
| 128 | DNA replication initiation (GO:0006270) | 2.62019546 |
| 129 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.61084286 |
| 130 | DNA synthesis involved in DNA repair (GO:0000731) | 2.57008502 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56217298 |
| 132 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.55084502 |
| 133 | DNA-dependent DNA replication (GO:0006261) | 2.54395876 |
| 134 | nucleobase biosynthetic process (GO:0046112) | 2.53943723 |
| 135 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53339541 |
| 136 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.52685089 |
| 137 | amino sugar catabolic process (GO:0046348) | 2.52665578 |
| 138 | intra-S DNA damage checkpoint (GO:0031573) | 2.52027382 |
| 139 | kinetochore organization (GO:0051383) | 2.51802648 |
| 140 | ncRNA catabolic process (GO:0034661) | 2.51785423 |
| 141 | deoxyribonucleotide catabolic process (GO:0009264) | 2.51711632 |
| 142 | transcription from RNA polymerase I promoter (GO:0006360) | 2.50597833 |
| 143 | RNA methylation (GO:0001510) | 2.50266421 |
| 144 | regulation of mitochondrial translation (GO:0070129) | 2.49925294 |
| 145 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.47601750 |
| 146 | histone H2A acetylation (GO:0043968) | 2.47384559 |
| 147 | regulation of gamma-delta T cell activation (GO:0046643) | 2.45765069 |
| 148 | methionine biosynthetic process (GO:0009086) | 2.43830865 |
| 149 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.42879517 |
| 150 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.41583906 |
| 151 | cellular response to interferon-beta (GO:0035458) | 2.41371692 |
| 152 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.41368183 |
| 153 | GDP-mannose metabolic process (GO:0019673) | 2.40553197 |
| 154 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.40009280 |
| 155 | ribosome biogenesis (GO:0042254) | 2.39591141 |
| 156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.38687467 |
| 157 | tolerance induction (GO:0002507) | 2.38325569 |
| 158 | ribosomal small subunit biogenesis (GO:0042274) | 2.38280090 |
| 159 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.37863030 |
| 160 | telomere maintenance (GO:0000723) | 2.36384688 |
| 161 | 7-methylguanosine mRNA capping (GO:0006370) | 2.35349900 |
| 162 | telomere organization (GO:0032200) | 2.35267628 |
| 163 | response to interferon-beta (GO:0035456) | 2.34860311 |
| 164 | dendritic cell chemotaxis (GO:0002407) | 2.34233104 |
| 165 | cellular response to interleukin-15 (GO:0071350) | 2.34205061 |
| 166 | maturation of SSU-rRNA (GO:0030490) | 2.33096396 |
| 167 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.32418798 |
| 168 | DNA replication-independent nucleosome organization (GO:0034724) | 2.32418798 |
| 169 | deoxyribose phosphate catabolic process (GO:0046386) | 2.32153605 |
| 170 | tRNA modification (GO:0006400) | 2.31717374 |
| 171 | regulation of B cell differentiation (GO:0045577) | 2.29940609 |
| 172 | doxorubicin metabolic process (GO:0044598) | 2.27450827 |
| 173 | daunorubicin metabolic process (GO:0044597) | 2.27450827 |
| 174 | polyketide metabolic process (GO:0030638) | 2.27450827 |
| 175 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.25936224 |
| 176 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.25685406 |
| 177 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.25685406 |
| 178 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.24217935 |
| 179 | regulation of metalloenzyme activity (GO:0048552) | 2.23797764 |
| 180 | 7-methylguanosine RNA capping (GO:0009452) | 2.23299998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.54784115 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.41316050 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91198645 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.85881048 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.85051775 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.75216980 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.72037411 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.66840484 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.58075244 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58070373 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50425736 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47295639 |
| 13 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37913796 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37750620 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.33258243 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30769691 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25818404 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24307474 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23073323 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.13430268 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.11216109 |
| 22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.09946301 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08095506 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04973618 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.00523038 |
| 26 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93742075 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90444323 |
| 28 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90242444 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83732735 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.82700214 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81295254 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80998916 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79757263 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.76286216 |
| 35 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.76024234 |
| 36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75384313 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72565596 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72204046 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71399303 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70868370 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69691111 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69372927 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69289308 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65793143 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.65469840 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.62097596 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58222367 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56392556 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53840823 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52369963 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51360848 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50550207 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48330749 |
| 54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.45657517 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42740579 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42113910 |
| 57 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41519525 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40351523 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40297959 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37507966 |
| 61 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.37008958 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36020831 |
| 63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35393295 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34461612 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33401627 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30425249 |
| 67 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27999369 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27000911 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26166885 |
| 70 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26033808 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26021147 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25672766 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24670676 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24513923 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.24237572 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23288403 |
| 77 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23027181 |
| 78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21712793 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21658461 |
| 80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20736241 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18127041 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17831729 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.17086787 |
| 84 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.15862439 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15195993 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14658676 |
| 87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14465944 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14115474 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13778892 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13623669 |
| 91 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13047888 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12776946 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12764675 |
| 94 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.09785006 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.09720594 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09719698 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09537542 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09470155 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07062381 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06936937 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05966822 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05508384 |
| 103 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.04482156 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03033288 |
| 105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02809964 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02664086 |
| 107 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02292181 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.02012704 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01955686 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 1.00920344 |
| 111 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00598424 |
| 112 | MYC_22102868_ChIP-Seq_BL_Human | 1.00152102 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00125428 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00022927 |
| 115 | MYB_26560356_Chip-Seq_TH1_Human | 0.99452344 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98068664 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97911095 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97691755 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97543050 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97226318 |
| 121 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97210516 |
| 122 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94494090 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94040300 |
| 124 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93029891 |
| 125 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92887888 |
| 126 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92771649 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92739394 |
| 128 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92653427 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91656998 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91568188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.07837462 |
| 2 | MP0008058_abnormal_DNA_repair | 2.85456675 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.74874891 |
| 4 | MP0010030_abnormal_orbit_morphology | 2.71761395 |
| 5 | MP0005671_abnormal_response_to | 2.68670008 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.64999931 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.59011807 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.48361295 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.45884330 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.43203757 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.37377513 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.29172813 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.27867473 |
| 14 | MP0002132_abnormal_respiratory_system | 2.27148332 |
| 15 | MP0009785_altered_susceptibility_to | 2.22489317 |
| 16 | MP0001800_abnormal_humoral_immune | 2.18049007 |
| 17 | MP0003878_abnormal_ear_physiology | 2.17475971 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 2.17475971 |
| 19 | MP0003866_abnormal_defecation | 2.12591021 |
| 20 | MP0003718_maternal_effect | 2.11943828 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.08354350 |
| 22 | MP0009840_abnormal_foam_cell | 2.02307528 |
| 23 | MP0000490_abnormal_crypts_of | 1.99982178 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 1.94760634 |
| 25 | MP0001873_stomach_inflammation | 1.91884475 |
| 26 | MP0003077_abnormal_cell_cycle | 1.89075058 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.83280736 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.82109108 |
| 29 | MP0000685_abnormal_immune_system | 1.81704052 |
| 30 | MP0002398_abnormal_bone_marrow | 1.78865147 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.77254289 |
| 32 | MP0002723_abnormal_immune_serum | 1.77138083 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.76189623 |
| 34 | MP0005025_abnormal_response_to | 1.76127012 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.75679788 |
| 36 | MP0001853_heart_inflammation | 1.75353461 |
| 37 | MP0001819_abnormal_immune_cell | 1.75105740 |
| 38 | MP0005387_immune_system_phenotype | 1.74238801 |
| 39 | MP0001790_abnormal_immune_system | 1.74238801 |
| 40 | MP0003186_abnormal_redox_activity | 1.73499782 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.73145426 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.64909084 |
| 43 | MP0002419_abnormal_innate_immunity | 1.62943813 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.62455829 |
| 45 | MP0000716_abnormal_immune_system | 1.60572538 |
| 46 | MP0002722_abnormal_immune_system | 1.59600062 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.57989521 |
| 48 | MP0003724_increased_susceptibility_to | 1.52476071 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.47010426 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.45651310 |
| 51 | MP0002429_abnormal_blood_cell | 1.45559429 |
| 52 | MP0009278_abnormal_bone_marrow | 1.40078842 |
| 53 | MP0008057_abnormal_DNA_replication | 1.36049302 |
| 54 | MP0004147_increased_porphyrin_level | 1.35341534 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.34739445 |
| 56 | MP0002405_respiratory_system_inflammati | 1.33992822 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.33092357 |
| 58 | MP0003436_decreased_susceptibility_to | 1.32628173 |
| 59 | MP0000358_abnormal_cell_content/ | 1.32261291 |
| 60 | MP0001764_abnormal_homeostasis | 1.31409193 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.30376469 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.29293545 |
| 63 | MP0008469_abnormal_protein_level | 1.28767690 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.28028295 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.27586115 |
| 66 | MP0009379_abnormal_foot_pigmentation | 1.25562180 |
| 67 | MP0002938_white_spotting | 1.24683511 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.24152634 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.20308196 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.20081076 |
| 71 | MP0004381_abnormal_hair_follicle | 1.19196633 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.18829259 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.18512774 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.17238714 |
| 75 | MP0002163_abnormal_gland_morphology | 1.17069467 |
| 76 | MP0000343_altered_response_to | 1.16585188 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.13201875 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 1.12941971 |
| 79 | MP0000049_abnormal_middle_ear | 1.12918586 |
| 80 | MP0002019_abnormal_tumor_incidence | 1.11832760 |
| 81 | MP0006292_abnormal_olfactory_placode | 1.10397736 |
| 82 | MP0001293_anophthalmia | 1.07650056 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.07319605 |
| 84 | MP0005451_abnormal_body_composition | 1.05832011 |
| 85 | MP0005083_abnormal_biliary_tract | 1.02061269 |
| 86 | MP0003786_premature_aging | 1.00523186 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 0.98577300 |
| 88 | MP0001188_hyperpigmentation | 0.98300471 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.97503145 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.96763013 |
| 91 | MP0000350_abnormal_cell_proliferation | 0.96282870 |
| 92 | MP0000566_synostosis | 0.93786628 |
| 93 | MP0005670_abnormal_white_adipose | 0.92249689 |
| 94 | MP0009763_increased_sensitivity_to | 0.91970008 |
| 95 | MP0001119_abnormal_female_reproductive | 0.91882855 |
| 96 | MP0001881_abnormal_mammary_gland | 0.87613808 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.86416313 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.85869941 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.84599236 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.82497756 |
| 101 | MP0009697_abnormal_copulation | 0.82339388 |
| 102 | MP0003136_yellow_coat_color | 0.82263519 |
| 103 | MP0000858_altered_metastatic_potential | 0.81735979 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.81109280 |
| 105 | MP0002160_abnormal_reproductive_system | 0.80849263 |
| 106 | MP0000313_abnormal_cell_death | 0.80499831 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.80172426 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.80163557 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.80163557 |
| 110 | MP0008004_abnormal_stomach_pH | 0.79719587 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.79194917 |
| 112 | MP0003828_pulmonary_edema | 0.78448636 |
| 113 | MP0003252_abnormal_bile_duct | 0.78020719 |
| 114 | MP0008260_abnormal_autophagy | 0.77802022 |
| 115 | MP0005330_cardiomyopathy | 0.76886373 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.76808533 |
| 117 | MP0005395_other_phenotype | 0.76615311 |
| 118 | MP0001663_abnormal_digestive_system | 0.76416214 |
| 119 | MP0005409_darkened_coat_color | 0.76125109 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.76067073 |
| 121 | MP0009764_decreased_sensitivity_to | 0.75310274 |
| 122 | MP0008932_abnormal_embryonic_tissue | 0.75182716 |
| 123 | MP0005501_abnormal_skin_physiology | 0.73318573 |
| 124 | MP0001730_embryonic_growth_arrest | 0.73185839 |
| 125 | MP0005389_reproductive_system_phenotype | 0.71980402 |
| 126 | MP0001919_abnormal_reproductive_system | 0.71459003 |
| 127 | MP0002138_abnormal_hepatobiliary_system | 0.71395347 |
| 128 | MP0002080_prenatal_lethality | 0.71207028 |
| 129 | MP0003075_altered_response_to | 0.70883026 |
| 130 | MP0003303_peritoneal_inflammation | 0.69295204 |
| 131 | MP0005499_abnormal_olfactory_system | 0.67733493 |
| 132 | MP0005394_taste/olfaction_phenotype | 0.67733493 |
| 133 | MP0001529_abnormal_vocalization | 0.67656366 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.67123868 |
| 135 | MP0008995_early_reproductive_senescence | 0.66894854 |
| 136 | MP0001905_abnormal_dopamine_level | 0.63214570 |
| 137 | MP0005408_hypopigmentation | 0.59385971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.39547111 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.33599802 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.88022558 |
| 4 | Acute encephalopathy (HP:0006846) | 4.86671285 |
| 5 | Increased CSF lactate (HP:0002490) | 4.16317595 |
| 6 | Progressive macrocephaly (HP:0004481) | 4.15484270 |
| 7 | Petechiae (HP:0000967) | 3.98636403 |
| 8 | Renal Fanconi syndrome (HP:0001994) | 3.97103101 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.91294355 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.87617637 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.76073251 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.75253942 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.75253942 |
| 14 | Pallor (HP:0000980) | 3.69494518 |
| 15 | Increased muscle lipid content (HP:0009058) | 3.67400844 |
| 16 | Chronic otitis media (HP:0000389) | 3.63363327 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.61039682 |
| 18 | Cerebral edema (HP:0002181) | 3.50192597 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.47972448 |
| 20 | Birth length less than 3rd percentile (HP:0003561) | 3.43885284 |
| 21 | * Panhypogammaglobulinemia (HP:0003139) | 3.38562128 |
| 22 | Thyroid-stimulating hormone excess (HP:0002925) | 3.33670027 |
| 23 | Chromsome breakage (HP:0040012) | 3.29961217 |
| 24 | Lactic acidosis (HP:0003128) | 3.25620865 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 3.03024050 |
| 26 | Respiratory difficulties (HP:0002880) | 3.01972965 |
| 27 | Exercise intolerance (HP:0003546) | 3.01615706 |
| 28 | IgM deficiency (HP:0002850) | 3.01105192 |
| 29 | Respiratory failure (HP:0002878) | 3.01060438 |
| 30 | * Agammaglobulinemia (HP:0004432) | 2.91662039 |
| 31 | Breast hypoplasia (HP:0003187) | 2.87530455 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.83628674 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.69883041 |
| 34 | Reticulocytopenia (HP:0001896) | 2.66584234 |
| 35 | Thrombocytosis (HP:0001894) | 2.65377632 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.62694587 |
| 37 | Granulocytopenia (HP:0001913) | 2.54098595 |
| 38 | Aplastic anemia (HP:0001915) | 2.54069321 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 2.53053130 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53053130 |
| 41 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.45771232 |
| 42 | Myositis (HP:0100614) | 2.45400259 |
| 43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.43117314 |
| 44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.41727253 |
| 45 | Hypertensive crisis (HP:0100735) | 2.39817691 |
| 46 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37178565 |
| 47 | Degeneration of anterior horn cells (HP:0002398) | 2.36618817 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 2.36618817 |
| 49 | Stomach cancer (HP:0012126) | 2.35379930 |
| 50 | Macrocytic anemia (HP:0001972) | 2.29394367 |
| 51 | * Encephalitis (HP:0002383) | 2.27558134 |
| 52 | Abnormal protein glycosylation (HP:0012346) | 2.27324097 |
| 53 | Abnormal glycosylation (HP:0012345) | 2.27324097 |
| 54 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27324097 |
| 55 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27324097 |
| 56 | Leukodystrophy (HP:0002415) | 2.26803729 |
| 57 | Hyperglycinuria (HP:0003108) | 2.24952027 |
| 58 | Abnormality of reticulocytes (HP:0004312) | 2.24736650 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.24225113 |
| 60 | Abnormality of the preputium (HP:0100587) | 2.24172210 |
| 61 | Meckel diverticulum (HP:0002245) | 2.23642192 |
| 62 | Obstructive lung disease (HP:0006536) | 2.22873721 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22873721 |
| 64 | B lymphocytopenia (HP:0010976) | 2.22323281 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.22323281 |
| 66 | Lethargy (HP:0001254) | 2.21157371 |
| 67 | Bone marrow hypocellularity (HP:0005528) | 2.19910137 |
| 68 | Pancytopenia (HP:0001876) | 2.19855212 |
| 69 | Seborrheic dermatitis (HP:0001051) | 2.19659846 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.19426421 |
| 71 | Eosinophilia (HP:0001880) | 2.18869175 |
| 72 | * Meningitis (HP:0001287) | 2.18586979 |
| 73 | Clubbing of toes (HP:0100760) | 2.17795515 |
| 74 | Abnormality of renal resorption (HP:0011038) | 2.17584008 |
| 75 | Optic disc pallor (HP:0000543) | 2.15987847 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.15805244 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.15672207 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12539467 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.11998997 |
| 80 | * Recurrent viral infections (HP:0004429) | 2.11343213 |
| 81 | Retrobulbar optic neuritis (HP:0100654) | 2.09922807 |
| 82 | Optic neuritis (HP:0100653) | 2.09922807 |
| 83 | Overlapping toe (HP:0001845) | 2.09678992 |
| 84 | Nonimmune hydrops fetalis (HP:0001790) | 2.09486709 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 2.08392257 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07539952 |
| 87 | Colon cancer (HP:0003003) | 2.06666772 |
| 88 | Abnormality of the ileum (HP:0001549) | 2.06383949 |
| 89 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.06219093 |
| 90 | Testicular atrophy (HP:0000029) | 2.05278008 |
| 91 | Exertional dyspnea (HP:0002875) | 2.04260547 |
| 92 | Microcytic anemia (HP:0001935) | 2.03449047 |
| 93 | Pustule (HP:0200039) | 2.01941834 |
| 94 | Microretrognathia (HP:0000308) | 1.98856479 |
| 95 | Increased serum pyruvate (HP:0003542) | 1.98479248 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.96136436 |
| 97 | Cholecystitis (HP:0001082) | 1.96136436 |
| 98 | Hepatic necrosis (HP:0002605) | 1.93679023 |
| 99 | IgG deficiency (HP:0004315) | 1.93637070 |
| 100 | Abnormal trabecular bone morphology (HP:0100671) | 1.93605380 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 1.93375089 |
| 102 | Lymphoma (HP:0002665) | 1.92309931 |
| 103 | Prolonged partial thromboplastin time (HP:0003645) | 1.91796507 |
| 104 | Methylmalonic aciduria (HP:0012120) | 1.91058621 |
| 105 | Leukopenia (HP:0001882) | 1.90691607 |
| 106 | Muscle fiber atrophy (HP:0100295) | 1.90644255 |
| 107 | Oral leukoplakia (HP:0002745) | 1.89345322 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 1.89116216 |
| 109 | Optic nerve coloboma (HP:0000588) | 1.88216047 |
| 110 | Absent thumb (HP:0009777) | 1.88112487 |
| 111 | * Abnormality of T cell physiology (HP:0011840) | 1.88023256 |
| 112 | Megaloblastic anemia (HP:0001889) | 1.86639035 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.86606917 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86509380 |
| 115 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86187618 |
| 116 | Emotional lability (HP:0000712) | 1.85601788 |
| 117 | Prolonged bleeding time (HP:0003010) | 1.84872367 |
| 118 | Duplicated collecting system (HP:0000081) | 1.84610890 |
| 119 | Eczematoid dermatitis (HP:0000976) | 1.84497834 |
| 120 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.84146348 |
| 121 | Self-mutilation (HP:0000742) | 1.83461066 |
| 122 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82486377 |
| 123 | Orchitis (HP:0100796) | 1.81839489 |
| 124 | CNS demyelination (HP:0007305) | 1.81666624 |
| 125 | Abnormality of the renal collecting system (HP:0004742) | 1.81604139 |
| 126 | Broad distal phalanx of finger (HP:0009836) | 1.81492979 |
| 127 | Combined immunodeficiency (HP:0005387) | 1.80873881 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.80873782 |
| 129 | Hepatocellular necrosis (HP:0001404) | 1.80828837 |
| 130 | Renal cortical cysts (HP:0000803) | 1.80707860 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.78712996 |
| 132 | Microvesicular hepatic steatosis (HP:0001414) | 1.78425506 |
| 133 | Hypoplastic pelvis (HP:0008839) | 1.78376011 |
| 134 | Increased serum lactate (HP:0002151) | 1.77349866 |
| 135 | Rough bone trabeculation (HP:0100670) | 1.76548496 |
| 136 | Recurrent bronchitis (HP:0002837) | 1.76070366 |
| 137 | Truncus arteriosus (HP:0001660) | 1.75809197 |
| 138 | Skin rash (HP:0000988) | 1.74822686 |
| 139 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.74001861 |
| 140 | * Abnormality of T cells (HP:0002843) | 1.73995416 |
| 141 | Horseshoe kidney (HP:0000085) | 1.73889912 |
| 142 | Epistaxis (HP:0000421) | 1.73600905 |
| 143 | Hyperglycinemia (HP:0002154) | 1.73305241 |
| 144 | Vacuolated lymphocytes (HP:0001922) | 1.72899327 |
| 145 | Myelodysplasia (HP:0002863) | 1.72536518 |
| 146 | Abnormal pupillary function (HP:0007686) | 1.72074296 |
| 147 | Cellulitis (HP:0100658) | 1.71294608 |
| 148 | Abnormality of the axillary hair (HP:0100134) | 1.71293006 |
| 149 | Abnormality of secondary sexual hair (HP:0009888) | 1.71293006 |
| 150 | Congenital, generalized hypertrichosis (HP:0004540) | 1.69389486 |
| 151 | Nausea (HP:0002018) | 1.69268948 |
| 152 | Duodenal stenosis (HP:0100867) | 1.69203297 |
| 153 | Small intestinal stenosis (HP:0012848) | 1.69203297 |
| 154 | Increased cerebral lipofuscin (HP:0011813) | 1.69030459 |
| 155 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68477138 |
| 156 | * Recurrent fungal infections (HP:0002841) | 1.68407494 |
| 157 | Multiple enchondromatosis (HP:0005701) | 1.67462926 |
| 158 | Hypoplastic left heart (HP:0004383) | 1.67441986 |
| 159 | Abnormality of macrophages (HP:0004311) | 1.66988858 |
| 160 | Cleft eyelid (HP:0000625) | 1.66433280 |
| 161 | Hypokinesia (HP:0002375) | 1.65655830 |
| 162 | Cerebral palsy (HP:0100021) | 1.64220009 |
| 163 | Death in infancy (HP:0001522) | 1.63330892 |
| 164 | * Neutropenia (HP:0001875) | 1.61207071 |
| 165 | Type 2 muscle fiber atrophy (HP:0003554) | 1.61115237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 7.03320613 |
| 2 | IRAK3 | 4.50092311 |
| 3 | STK16 | 3.69673166 |
| 4 | ZAK | 3.60069029 |
| 5 | TIE1 | 3.43833617 |
| 6 | BUB1 | 3.25734892 |
| 7 | SMG1 | 3.25031286 |
| 8 | TNIK | 2.98186408 |
| 9 | TEC | 2.55286553 |
| 10 | NLK | 2.51747005 |
| 11 | IRAK4 | 2.38760180 |
| 12 | WEE1 | 2.29061498 |
| 13 | ERN1 | 2.11052896 |
| 14 | KIT | 2.08448285 |
| 15 | TXK | 2.08061266 |
| 16 | ZAP70 | 2.04591544 |
| 17 | MAP4K1 | 2.00208365 |
| 18 | NME1 | 1.94078548 |
| 19 | MAP2K3 | 1.93801500 |
| 20 | MAP3K11 | 1.91868550 |
| 21 | BRSK2 | 1.80784047 |
| 22 | TAF1 | 1.79245038 |
| 23 | NME2 | 1.58759710 |
| 24 | BCKDK | 1.54062608 |
| 25 | ARAF | 1.50829402 |
| 26 | LRRK2 | 1.50661303 |
| 27 | TLK1 | 1.46321775 |
| 28 | PBK | 1.45393365 |
| 29 | BTK | 1.44661033 |
| 30 | FLT3 | 1.43417659 |
| 31 | IRAK2 | 1.42007103 |
| 32 | IKBKB | 1.41825949 |
| 33 | TSSK6 | 1.38673171 |
| 34 | CLK1 | 1.33885399 |
| 35 | SRPK1 | 1.30326764 |
| 36 | NEK1 | 1.30212658 |
| 37 | GRK1 | 1.28104499 |
| 38 | PIK3CA | 1.27732942 |
| 39 | EIF2AK3 | 1.27334091 |
| 40 | TESK1 | 1.22499995 |
| 41 | IKBKE | 1.20267061 |
| 42 | CDK8 | 1.19533570 |
| 43 | TTK | 1.18303126 |
| 44 | MAP3K14 | 1.18009431 |
| 45 | ABL2 | 1.15378653 |
| 46 | IRAK1 | 1.15237913 |
| 47 | MKNK1 | 1.14627311 |
| 48 | EIF2AK2 | 1.10854490 |
| 49 | NUAK1 | 1.09921470 |
| 50 | MAP3K6 | 1.07989212 |
| 51 | PLK4 | 1.07583653 |
| 52 | PDK2 | 1.05769237 |
| 53 | DAPK3 | 1.03230274 |
| 54 | PIM2 | 1.00412428 |
| 55 | TESK2 | 1.00051213 |
| 56 | KDR | 0.99808067 |
| 57 | DAPK1 | 0.98983615 |
| 58 | AURKA | 0.96970451 |
| 59 | CHUK | 0.95639714 |
| 60 | JAK3 | 0.93850268 |
| 61 | STK4 | 0.93567372 |
| 62 | SIK3 | 0.93452475 |
| 63 | DYRK2 | 0.92855052 |
| 64 | BLK | 0.91221199 |
| 65 | ILK | 0.90983658 |
| 66 | EEF2K | 0.89637501 |
| 67 | CDK19 | 0.88804951 |
| 68 | TYK2 | 0.87514501 |
| 69 | VRK1 | 0.87369033 |
| 70 | MAP2K6 | 0.84750851 |
| 71 | PAK4 | 0.84029362 |
| 72 | STK10 | 0.83672551 |
| 73 | MKNK2 | 0.83618078 |
| 74 | BRSK1 | 0.80856177 |
| 75 | LIMK1 | 0.80643948 |
| 76 | TBK1 | 0.79922526 |
| 77 | ITK | 0.78977245 |
| 78 | ADRBK2 | 0.78620921 |
| 79 | CDK3 | 0.73946192 |
| 80 | PLK1 | 0.72448530 |
| 81 | PIM1 | 0.72219001 |
| 82 | ATR | 0.71550078 |
| 83 | RPS6KA4 | 0.71152155 |
| 84 | MAP3K7 | 0.70745433 |
| 85 | SYK | 0.70381791 |
| 86 | YES1 | 0.68601192 |
| 87 | MAPK11 | 0.68535884 |
| 88 | MAP3K3 | 0.67217083 |
| 89 | CDC7 | 0.66702000 |
| 90 | MAPKAPK3 | 0.66665001 |
| 91 | LYN | 0.66497567 |
| 92 | EPHA2 | 0.65875316 |
| 93 | CSNK1G3 | 0.65573512 |
| 94 | MAPKAPK5 | 0.63889598 |
| 95 | MARK3 | 0.63058969 |
| 96 | CSF1R | 0.62671659 |
| 97 | RPS6KA5 | 0.62499923 |
| 98 | AURKB | 0.62248123 |
| 99 | CCNB1 | 0.61059853 |
| 100 | LCK | 0.60652412 |
| 101 | CDK7 | 0.58502105 |
| 102 | PRKAA2 | 0.58434240 |
| 103 | MAP2K2 | 0.57269335 |
| 104 | RIPK4 | 0.57000220 |
| 105 | RPS6KB2 | 0.56788309 |
| 106 | CSNK2A2 | 0.56722186 |
| 107 | PASK | 0.54266838 |
| 108 | EIF2AK1 | 0.52528551 |
| 109 | CDK9 | 0.51190712 |
| 110 | TNK2 | 0.50793654 |
| 111 | MYLK | 0.50749462 |
| 112 | NEK2 | 0.50441620 |
| 113 | FES | 0.49780923 |
| 114 | AKT3 | 0.49421242 |
| 115 | DYRK3 | 0.48201303 |
| 116 | EPHB2 | 0.47407466 |
| 117 | TRIB3 | 0.47232511 |
| 118 | PRKCI | 0.46045293 |
| 119 | SCYL2 | 0.45945302 |
| 120 | MAPK7 | 0.44916236 |
| 121 | PAK1 | 0.43708006 |
| 122 | RAF1 | 0.40083578 |
| 123 | BRAF | 0.39936291 |
| 124 | CDK4 | 0.39663477 |
| 125 | MAPKAPK2 | 0.39414805 |
| 126 | TAOK2 | 0.38014933 |
| 127 | MUSK | 0.37832172 |
| 128 | CSNK1A1L | 0.37808587 |
| 129 | PRKD3 | 0.37702673 |
| 130 | MAPK4 | 0.37156453 |
| 131 | TAOK1 | 0.36195567 |
| 132 | CHEK2 | 0.34780517 |
| 133 | PLK3 | 0.31707592 |
| 134 | SGK2 | 0.30861121 |
| 135 | CHEK1 | 0.30644047 |
| 136 | MAP3K8 | 0.29805860 |
| 137 | TGFBR1 | 0.29451044 |
| 138 | CSNK2A1 | 0.29108125 |
| 139 | GRK6 | 0.28968680 |
| 140 | TRPM7 | 0.27699876 |
| 141 | NEK6 | 0.27388539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.45301633 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.90733050 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.80700616 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.59726804 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.55761624 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.52552296 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.51574258 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.44134633 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.25791804 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25444240 |
| 11 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 2.21418462 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.17275384 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.13732687 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.01818799 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.82522683 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.75992239 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.69742729 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.65786488 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61586936 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.60934570 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.60852706 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.56579469 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56269988 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42602186 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38512357 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30412948 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.30049152 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.29091541 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28678444 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28599189 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27243198 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25803723 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25614393 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23716934 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20166975 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 1.17515460 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15543150 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10751025 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09184714 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08502477 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05559407 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04856346 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04838852 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.04541290 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03712357 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03698239 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03446089 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03022487 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02776805 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99989675 |
| 51 | Measles_Homo sapiens_hsa05162 | 0.99343799 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97859651 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97700679 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97520082 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.96957259 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96343620 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94419829 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94354080 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94117040 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94055651 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91775998 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89073747 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.88603334 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88320202 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85666297 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.85309802 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.83119722 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79992343 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79602636 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79308275 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79155765 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77586243 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72523634 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71741858 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70568958 |
| 76 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69149262 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68671143 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67213991 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.66169952 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65336260 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64042239 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63755813 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62606879 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60926241 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60525782 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58359459 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58042392 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57961333 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56744051 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.56473022 |
| 91 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55576108 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54001200 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53579889 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51415568 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.49911986 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.49056985 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47120445 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46400315 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46242768 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45352814 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45140868 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44241500 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43439975 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42230224 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41840022 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40511864 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40198537 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40169077 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.39861796 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39557480 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39286812 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38609924 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37954278 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37808215 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37628651 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37289276 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.36995497 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36158279 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.34349741 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33009413 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31928952 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26893506 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23406397 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23396472 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23244095 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22789264 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.21412580 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20695728 |
| 129 | Lysosome_Homo sapiens_hsa04142 | 0.20418318 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.20058613 |
| 131 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.16859709 |
| 132 | * Tuberculosis_Homo sapiens_hsa05152 | 0.15023023 |

